Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma

  1. Moreau, P.
  2. Van De Donk, N.W.C.J.
  3. Nahi, H.
  4. Oriol, A.
  5. Nooka, A.K.
  6. Martin, T.
  7. Rosinol, L.
  8. Karlin, L.
  9. Benboubker, L.
  10. Mateos, M.-V.
  11. Popat, R.
  12. Martínez-López, J.
  13. Sidana, S.
  14. Delforge, M.
  15. Pei, L.
  16. Trancucci, D.
  17. Olyslager, Y.
  18. Uhlar, C.
  19. Stephenson, T.
  20. Rampelbergh, R.V.
  21. Banerjee, A.
  22. Kobos, R.
  23. Usmani, S.Z.
Revue:
Future Oncology

ISSN: 1744-8301,  1479-6694

Année de publication: 2023

Volumen: 19

Número: 12

Pages: 811-818

Type: Révision

DOI: 10.2217/FON-2023-0171 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus